ATTD START-UP GRANTS
ATTD is delighted to announce the introduction of its ATTD Start-Up Grants to be offered to 5 outstanding start-up companies presenting an innovative product currently in the pipeline. Apply to receive a €2,500 grant (plus further benefits) and participate at the prestigious International Fair of New Technologies during ATTD 2016, taking place in Milan, Italy, February 3-6, 2016.
Meet the Experts. Discover the Latest Research. Behold the Next Big Thing. The International Fair of New Technologies in Diabetes: where start-ups and emerging companies will be displaying cutting edge technologies and medical devices for diabetes treatment. Be at ATTD 2016, the forefront of this constantly evolving discipline.
For more information click here.
HELmSLEY CHARITABLE TRUST
Diabetes Data Innovation Initiative
The Type 1 Diabetes Program of The Leona M. and Harry B. Helmsley Charitable Trust today announced the launch of the Diabetes Data Innovation Initiative, through which it will provide up to $5 million in funding over the next two years for innovative solutions that enable the use of data to ease the burden of type 1 diabetes (T1D) for those living with the disease, their caregivers and healthcare providers.
This new initiative of the Trust has issued a request for proposals to identify high-potential projects and pioneering digital health solutions that could enable the integration of diabetes data to identify trends and develop personalized patient guidance and decision support for providers.
Over the past decade, advances in medical device technologies have made a significant impact on the monitoring, management and treatment of T1D. However, data from the T1D Exchange demonstrates that, due to the complexity of the disease, the majority of people with T1D are not achieving optimal health outcomes despite today's tools, and many report feeling overwhelmed by information on insulin dosing, blood glucose values, exercise, meals and other sources.
Aggregating data and transforming it into actionable knowledge has the power to play a profound role in improving therapies and the overall daily management of the disease, resulting in better glucose control, health outcomes and quality of life. With this funding initiative, the Trust will consider new and advanced projects including, but not limited to, mobile platforms and applications, electronic medical records and electronic health records, embedded wireless sensors and communications, and big data analytics. Integration with consumer, patient and healthcare professional devices and platforms will likely be essential.
More information about the Diabetes Data Innovation Initiative and the related request for proposals can be found on the Trust's website at www.helmsleytrust.org/diabetes-data-innovation-initiative.
ABOUT THE HELMSLEY CHARITABLE TRUST
The Leona M. and Harry B. Helmsley Charitable Trust aspires to improve lives by supporting exceptional nonprofits and other mission-aligned organizations in health, selected place-based initiatives, and education and human services. Since 2008, when the Trust began its active grant making, it has committed more than $1 billion. The Helmsley Type 1 Diabetes Program is the largest private foundation funder of T1D in the United States focused on understanding the disease, developing better treatments and improving care and access.
For more information, visit www.helmsleytrust.org.
Information about additional grants coming soon.